T2* Relaxometry in Patients with Parkinson's Disease : Use of an Automated Atlas-based Approach.

about

T2* Relaxometry in Patients with Parkinson's Disease : Use of an Automated Atlas-based Approach.

Item

http://www.wikidata.org/entity/Q40384244

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

T2* Relaxometry in Patients wi ...... utomated Atlas-based Approach.

@en

type

Item

label

T2* Relaxometry in Patients wi ...... utomated Atlas-based Approach.

@en

prefLabel

T2* Relaxometry in Patients wi ...... utomated Atlas-based Approach.

@en

P1476

T2* Relaxometry in Patients wi ...... Automated Atlas-based Approach

@en

P2093

Christoph P Kaller

http://www.w3.org/2001/XMLSchema#string

Cornelius Weiller

http://www.w3.org/2001/XMLSchema#string

Florian Amtage

http://www.w3.org/2001/XMLSchema#string

Horst Urbach

http://www.w3.org/2001/XMLSchema#string

Irina Mader

http://www.w3.org/2001/XMLSchema#string

Julia Koenigsdorf

http://www.w3.org/2001/XMLSchema#string

Karl Egger

http://www.w3.org/2001/XMLSchema#string

Ralf Schwarzwald

http://www.w3.org/2001/XMLSchema#string

Shan Yang

http://www.w3.org/2001/XMLSchema#string

P2860

A fast diffeomorphic image registration algorithm

Parkinsonism: onset, progression and mortality

Measures of the Amount of Ecologic Association Between Species

Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.

In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease

Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature.

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.

Exponential excitation pulses for improved water content mapping in the presence of background gradients.

Imaging nigral pathology and clinical progression in Parkinson's disease.

Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging.

P2888

s00062-016-0523-2

P304

63-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00062-016-0523-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lena V Schumacher

Markus Obmann

P577

2016-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27334101

http://www.w3.org/2001/XMLSchema#string